Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer by Mah, CY, Nguyen, ADT, Niijima, T, Helm, M, Dehairs, J, Ryan, FJ, Ryan, N, Quek, L, Hoy, AJ, Don, AS, Mills, IG, Swinnen, JV, Lynn, DJ, Nassar, ZD, Butler, LM

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer by Centenera, MM, Scott, JS, Machiels, J, Nassar, ZD, Miller, DC, Zininos, I, Dehairs, J, Burvenich, IJG, Zadra, G, Chetta, P, Bango, C, Evergren, E, Ryan, NK, Gillis, JL, Mah, CY, Tieu, T, Hanson, AR, Carelli, R, Bloch, K, Panagopoulos, V, Waelkens, E, Derua, R, Williams, ED, Evdokioou, A, Cifuentes-Rius, A, Voelcker, NH, Mills, IG, Tilley, WD, Scott, AM, Loda, M, Selth, LA, Swinnen, JV, Butler, LM

Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity by Vriens, K, Christen, S, Parik, S, Broekaert, D, Yoshinaga, K, Talebi, A, Dehairs, J, Escalona-Noguero, C, Schmieder, R, Cornfield, T, Charlton, C, Romero-Pérez, L, Rossi, M, Rinaldi, G, Orth, M, Boon, R, Kerstens, A, Kwan, S, Faubert, B, Méndez-Lucas, A, Kopitz, C, Chen, T, Fernandez-Garcia, J, Duarte, J, Schmitz, A, Steigemann, P, Najimi, M, Hägebarth, A, Van Ginderachter, J, Sokal, E, Gotoh, N, Wong, K, Verfaillie, C, Derua, R, Munck, S, Yuneva, M, Beretta, L, Deberardinis, R, Swinnen, J, Hodson, L, Cassiman, D, Verslype, C, Christian, S, Grünewald, S, Grünewald, T, Fendt, S